Endo Pharmaceuticals To Announce Fourth Quarter 2014 Financial Results On March 2, 2015

DUBLIN, Feb. 13, 2015 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) (TSX: ENL) will announce its fourth quarter 2014 financial results before the open of the U.S. financial markets on March 2, 2015 and members of its senior management team will host a conference call and webcast at 8:30 a.m. ET that day. 

The dial-in number to access the call is U.S./Canada (877) 415-3182, International (857) 244-7325, and the passcode is 81514356. Please dial in 10 minutes prior to the scheduled start time.

A replay of the call will be available from March 2, 2015 at 12:30 p.m. ET until 11:59 p.m. ET on March 10, 2015 by dialing (888) 286-8010 (U.S./Canada) or (617) 801-6888 (International) and entering the passcode 23071815.

A simultaneous webcast of the call can be accessed by visiting www.endo.com. In addition, a replay of the webcast will be available until 11:59 p.m. ET on March 10, 2015. The replay can be accessed by clicking on "Events" in the Investor Relations section of the website.

About Endo International plc

Endo International plc is a global specialty healthcare company focused on improving patients' lives while creating shareholder value. Endo develops, manufactures, markets, and distributes quality branded pharmaceutical, generic pharmaceutical, over the counter medications and medical device products through its operating companies. Endo has global headquarters in Dublin, Ireland, and U.S. headquarters in Malvern, PA. Learn more at www.endo.com.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/endo-to-announce-fourth-quarter-2014-financial-results-on-march-2-2015-300035748.html

SOURCE Endo International plc